GI
ICPT

Gradient Investments’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Gradient Investments’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-21
Closed -$3K – 797
2015
Q4 		$3K Hold
21
– – ﹤0.01% 564
2015
Q3 		$3K Hold
21
– – ﹤0.01% 501
2015
Q2 		$5K Sell
21
-23
-52% -$6.13K ﹤0.01% 475
2015
Q1 		$12K Sell
44
-1,929
-98% -$418K ﹤0.01% 387
2014
Q4 		$308K Sell
1,973
-218
-10% -$40.3K 0.05% 151
2014
Q3 		$519K Buy
2,191
+103
+5% +$26.3K 0.09% 128
2014
Q2 		$494K Buy
+2,088
New +$550K 0.1% 129

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Gradient Investments's ICPT Position: Q1 2016 in Review

Gradient Investments sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2016, closing a stake of 21 shares — an estimated $3K sold.

Gradient Investments first reported a position in ICPT in Q2 2014 and held it in 7 quarters. The position peaked at $519K in Q3 2014. 160 funds tracked by Wall St. Rank hold ICPT as of Q1 2016.

  • Gradient Investments reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Gradient Investments sold 21 Intercept Pharmaceuticals, Inc. shares in Q1 2016, an estimated $3K.
  • Gradient Investments first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 7 quarters.
  • Gradient Investments's Intercept Pharmaceuticals, Inc. position peaked at $519K in Q3 2014.
  • 160 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2016.

Based on Gradient Investments's 13F filing for Q1 2016, filed 13 Apr 2016.